Nagendran Sukumar sold TSHA
January 26, 2026 · Form 4 insider transaction
Nagendran Sukumar sold 26,918 shares of Taysha Gene Therapies, Inc. at $4.61 per share, a transaction worth $124.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
26,918
Price
$4.61
Total value
$124.1K
InsiderNagendran Sukumar
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 26, 2026
Filing dateJanuary 27, 2026
Shares owned after1,317,389
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.; The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive.